Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03

AUTHORS

F Farace, M Gross-Goupil, E Tournay, M Taylor, N Vimond, N Jacques, F Billiot, A Mauguen, C Hill, B Escudier

ABSTRACT

BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI). METHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1 ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1α and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined. RESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1α, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1α levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1α levels were associated with OS (P=0.02, P=0.007). CONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1α levels could be of clinical interest in TKI-treated mRCC pts to predict outcome. More... »

PAGES

1144

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2011.72

DOI

http://dx.doi.org/10.1038/bjc.2011.72

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027792566

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21386843


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD34", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Common Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor Receptor-2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France", 
            "INSERM U 981 \u2018Identification of molecular predictors and new targets for cancer treatment\u2019, Institut de Canc\u00e9rologie Gustave Roussy, University of Paris-Sud, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farace", 
        "givenName": "F", 
        "id": "sg:person.01126051072.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126051072.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medicine, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gross-Goupil", 
        "givenName": "M", 
        "id": "sg:person.01252672277.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252672277.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tournay", 
        "givenName": "E", 
        "id": "sg:person.01360076563.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360076563.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France", 
            "INSERM U 981 \u2018Identification of molecular predictors and new targets for cancer treatment\u2019, Institut de Canc\u00e9rologie Gustave Roussy, University of Paris-Sud, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "M", 
        "id": "sg:person.0660375370.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660375370.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vimond", 
        "givenName": "N", 
        "id": "sg:person.01036122025.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036122025.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jacques", 
        "givenName": "N", 
        "id": "sg:person.0770006625.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770006625.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Billiot", 
        "givenName": "F", 
        "id": "sg:person.01360655007.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655007.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mauguen", 
        "givenName": "A", 
        "id": "sg:person.01362554046.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362554046.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "C", 
        "id": "sg:person.0601364507.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601364507.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medicine, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Escudier", 
        "givenName": "B", 
        "id": "sg:person.01304252172.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/emboj/18.14.3964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000096470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0708148104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000397108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2006.11.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000989893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-5-32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001875982", 
          "https://doi.org/10.1186/1479-5876-5-32"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0507158102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002444282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0710516105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004176363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa065044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007947936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013847179", 
          "https://doi.org/10.1038/nrc2442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-1443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014291431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.5511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017988502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018735013", 
          "https://doi.org/10.1038/nrc1946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018735013", 
          "https://doi.org/10.1038/nrc1946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020541056", 
          "https://doi.org/10.1038/nm1200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020541056", 
          "https://doi.org/10.1038/nm1200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020767820", 
          "https://doi.org/10.1038/sj.bjc.6605477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020767820", 
          "https://doi.org/10.1038/sj.bjc.6605477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gad.436307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023814636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025111240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(05)68049-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027421869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(05)68049-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027421869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.05592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034339541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035947940", 
          "https://doi.org/10.1038/sj.bjc.6604383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jim.2008.07.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037057792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-2363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038609521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040378769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1150224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044864905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1101-1194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050308225", 
          "https://doi.org/10.1038/nm1101-1194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1101-1194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050308225", 
          "https://doi.org/10.1038/nm1101-1194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1127592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062453796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th04-09-0578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063290288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075221300", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03", 
    "datePublishedReg": "2011-03-01", 
    "description": "BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI).\nMETHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1\u2009ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1\u03b1 and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined.\nRESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1\u03b1, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1\u03b1 levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1\u03b1 levels were associated with OS (P=0.02, P=0.007).\nCONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1\u03b1 levels could be of clinical interest in TKI-treated mRCC pts to predict outcome.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2011.72", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "104"
      }
    ], 
    "name": "Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors", 
    "pagination": "1144", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "84656fe8ffc182c7d727ba4587ff677233bd17a17f76c89b9f6449d3a66a011e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21386843"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2011.72"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027792566"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2011.72", 
      "https://app.dimensions.ai/details/publication/pub.1027792566"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000435.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc201172"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'


 

This table displays all metadata directly associated to this object as RDF triples.

301 TRIPLES      21 PREDICATES      76 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2011.72 schema:about N13fab8f1e67045628d8c29f716073995
2 N1caf8134b9814b8180aa5ba097c76918
3 N1df6a1b640cc499ba2cbccc98dd325e4
4 N2a79939ff69d4a7a9e40621a9b4b1129
5 N58e10facb04d486084415131387535af
6 N6cd9b1a1512544098fe98f09c6a78dbc
7 N7f5cd39f3f1a434c9205938c7b3ca2fe
8 N8ecf5a42598a42c0a30f9ab31c6a71bc
9 N9b084c6a40ff44cdbc65ef8fb7e8fa85
10 N9bf2eaf51bf4402ebfde7cb0db629df7
11 N9f726d53def44231a2435acb57d8f33a
12 Na612991ee8754dbc8978ef4b8b9e54b1
13 Nb2be59a20f3749cf8515314a5180a4fe
14 Nd1b12ea3466f4a3da786a85c087e048f
15 Ne7f8c4c075c942e2bf2f713231cccd42
16 Ne87965affbcf4ee6b575d8064fde7ab5
17 Nfb6aca15843f4958bddfc59e23e03f51
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N3bc0976c23944cadbff5db8a56d1454b
21 schema:citation sg:pub.10.1038/nature04186
22 sg:pub.10.1038/nm1101-1194
23 sg:pub.10.1038/nm1200
24 sg:pub.10.1038/nm988
25 sg:pub.10.1038/nrc1946
26 sg:pub.10.1038/nrc2442
27 sg:pub.10.1038/sj.bjc.6604383
28 sg:pub.10.1038/sj.bjc.6605477
29 sg:pub.10.1186/1479-5876-5-32
30 https://app.dimensions.ai/details/publication/pub.1075221300
31 https://doi.org/10.1016/j.ccr.2006.11.021
32 https://doi.org/10.1016/j.jim.2008.07.006
33 https://doi.org/10.1016/s0022-5347(05)68049-4
34 https://doi.org/10.1056/nejmoa060655
35 https://doi.org/10.1056/nejmoa065044
36 https://doi.org/10.1073/pnas.0507158102
37 https://doi.org/10.1073/pnas.0708148104
38 https://doi.org/10.1073/pnas.0710516105
39 https://doi.org/10.1093/annonc/mdm367
40 https://doi.org/10.1093/emboj/18.14.3964
41 https://doi.org/10.1097/moh.0b013e32832bbcab
42 https://doi.org/10.1101/gad.436307
43 https://doi.org/10.1126/science.1127592
44 https://doi.org/10.1126/science.1150224
45 https://doi.org/10.1158/0008-5472.can-04-1443
46 https://doi.org/10.1158/1078-0432.ccr-08-2363
47 https://doi.org/10.1160/th04-09-0578
48 https://doi.org/10.1200/jco.2005.01.186
49 https://doi.org/10.1200/jco.2008.19.5511
50 https://doi.org/10.1593/neo.05592
51 schema:datePublished 2011-03
52 schema:datePublishedReg 2011-03-01
53 schema:description BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI). METHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1 ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1α and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined. RESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1α, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1α levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1α levels were associated with OS (P=0.02, P=0.007). CONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1α levels could be of clinical interest in TKI-treated mRCC pts to predict outcome.
54 schema:genre research_article
55 schema:inLanguage en
56 schema:isAccessibleForFree true
57 schema:isPartOf Nafc74e501921473b854b637b3d469a5c
58 Nb22ede4d78d34817b467dfc5ea499ca5
59 sg:journal.1017082
60 schema:name Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
61 schema:pagination 1144
62 schema:productId N0da450dfb5264b8e9334a72c2e857715
63 N2d52a87ad1e0422a9c010bfde108f927
64 N30cd94e2ea684244a831585f0ea1130e
65 N3bffef6e73e141069ae7bf62fe24ab34
66 Nc25dc4c2f8244d89b4ebe43990d99c99
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027792566
68 https://doi.org/10.1038/bjc.2011.72
69 schema:sdDatePublished 2019-04-11T01:48
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher Nc1dfdac4fc684d16b6e067e3876a87c8
72 schema:url https://www.nature.com/articles/bjc201172
73 sgo:license sg:explorer/license/
74 sgo:sdDataset articles
75 rdf:type schema:ScholarlyArticle
76 N0da450dfb5264b8e9334a72c2e857715 schema:name doi
77 schema:value 10.1038/bjc.2011.72
78 rdf:type schema:PropertyValue
79 N13fab8f1e67045628d8c29f716073995 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Leukocyte Common Antigens
81 rdf:type schema:DefinedTerm
82 N1caf8134b9814b8180aa5ba097c76918 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Adult
84 rdf:type schema:DefinedTerm
85 N1df6a1b640cc499ba2cbccc98dd325e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Male
87 rdf:type schema:DefinedTerm
88 N24ae3bf78df94d0d8d4d3f872e00528f rdf:first sg:person.0770006625.60
89 rdf:rest Na47bbc623a784911917d6cf8d1a9361a
90 N2a79939ff69d4a7a9e40621a9b4b1129 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Vascular Endothelial Growth Factor A
92 rdf:type schema:DefinedTerm
93 N2d52a87ad1e0422a9c010bfde108f927 schema:name pubmed_id
94 schema:value 21386843
95 rdf:type schema:PropertyValue
96 N30cd94e2ea684244a831585f0ea1130e schema:name nlm_unique_id
97 schema:value 0370635
98 rdf:type schema:PropertyValue
99 N3bc0976c23944cadbff5db8a56d1454b rdf:first sg:person.01126051072.51
100 rdf:rest Ne0a6cbd5bec7413eace6951a78ebc6c4
101 N3bffef6e73e141069ae7bf62fe24ab34 schema:name dimensions_id
102 schema:value pub.1027792566
103 rdf:type schema:PropertyValue
104 N3eee836044b44482a3d5208f6ca1b19f rdf:first sg:person.01360076563.47
105 rdf:rest N7eab7596db1e41a48d39af8e8a9e402e
106 N485102cb4f4948519263d0864d01976a rdf:first sg:person.01036122025.82
107 rdf:rest N24ae3bf78df94d0d8d4d3f872e00528f
108 N58e10facb04d486084415131387535af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Protein-Tyrosine Kinases
110 rdf:type schema:DefinedTerm
111 N6cd9b1a1512544098fe98f09c6a78dbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Carcinoma, Renal Cell
113 rdf:type schema:DefinedTerm
114 N7b538d01fe904f72a7dd28a64c70bc98 rdf:first sg:person.0601364507.58
115 rdf:rest N9b95cb05152a4c86a5386ae492c6c1ea
116 N7eab7596db1e41a48d39af8e8a9e402e rdf:first sg:person.0660375370.75
117 rdf:rest N485102cb4f4948519263d0864d01976a
118 N7f5cd39f3f1a434c9205938c7b3ca2fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 N8ecf5a42598a42c0a30f9ab31c6a71bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Outcome
123 rdf:type schema:DefinedTerm
124 N9b084c6a40ff44cdbc65ef8fb7e8fa85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Protein Kinase Inhibitors
126 rdf:type schema:DefinedTerm
127 N9b95cb05152a4c86a5386ae492c6c1ea rdf:first sg:person.01304252172.82
128 rdf:rest rdf:nil
129 N9bf2eaf51bf4402ebfde7cb0db629df7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged
131 rdf:type schema:DefinedTerm
132 N9f726d53def44231a2435acb57d8f33a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Female
134 rdf:type schema:DefinedTerm
135 Na47bbc623a784911917d6cf8d1a9361a rdf:first sg:person.01360655007.23
136 rdf:rest Nb3fab29d7cee4302abd29e10c0641e35
137 Na612991ee8754dbc8978ef4b8b9e54b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Vascular Endothelial Growth Factor Receptor-2
139 rdf:type schema:DefinedTerm
140 Nafc74e501921473b854b637b3d469a5c schema:volumeNumber 104
141 rdf:type schema:PublicationVolume
142 Nb22ede4d78d34817b467dfc5ea499ca5 schema:issueNumber 7
143 rdf:type schema:PublicationIssue
144 Nb2be59a20f3749cf8515314a5180a4fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Antigens, CD34
146 rdf:type schema:DefinedTerm
147 Nb3fab29d7cee4302abd29e10c0641e35 rdf:first sg:person.01362554046.97
148 rdf:rest N7b538d01fe904f72a7dd28a64c70bc98
149 Nc1dfdac4fc684d16b6e067e3876a87c8 schema:name Springer Nature - SN SciGraph project
150 rdf:type schema:Organization
151 Nc25dc4c2f8244d89b4ebe43990d99c99 schema:name readcube_id
152 schema:value 84656fe8ffc182c7d727ba4587ff677233bd17a17f76c89b9f6449d3a66a011e
153 rdf:type schema:PropertyValue
154 Nd1b12ea3466f4a3da786a85c087e048f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Hematopoietic Stem Cells
156 rdf:type schema:DefinedTerm
157 Ne0a6cbd5bec7413eace6951a78ebc6c4 rdf:first sg:person.01252672277.93
158 rdf:rest N3eee836044b44482a3d5208f6ca1b19f
159 Ne7f8c4c075c942e2bf2f713231cccd42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Humans
161 rdf:type schema:DefinedTerm
162 Ne87965affbcf4ee6b575d8064fde7ab5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Kidney Neoplasms
164 rdf:type schema:DefinedTerm
165 Nfb6aca15843f4958bddfc59e23e03f51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged, 80 and over
167 rdf:type schema:DefinedTerm
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
172 schema:name Clinical Sciences
173 rdf:type schema:DefinedTerm
174 sg:journal.1017082 schema:issn 0007-0920
175 1532-1827
176 schema:name British Journal of Cancer
177 rdf:type schema:Periodical
178 sg:person.01036122025.82 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
179 schema:familyName Vimond
180 schema:givenName N
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036122025.82
182 rdf:type schema:Person
183 sg:person.01126051072.51 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
184 schema:familyName Farace
185 schema:givenName F
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126051072.51
187 rdf:type schema:Person
188 sg:person.01252672277.93 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
189 schema:familyName Gross-Goupil
190 schema:givenName M
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252672277.93
192 rdf:type schema:Person
193 sg:person.01304252172.82 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
194 schema:familyName Escudier
195 schema:givenName B
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82
197 rdf:type schema:Person
198 sg:person.01360076563.47 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
199 schema:familyName Tournay
200 schema:givenName E
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360076563.47
202 rdf:type schema:Person
203 sg:person.01360655007.23 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
204 schema:familyName Billiot
205 schema:givenName F
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655007.23
207 rdf:type schema:Person
208 sg:person.01362554046.97 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
209 schema:familyName Mauguen
210 schema:givenName A
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362554046.97
212 rdf:type schema:Person
213 sg:person.0601364507.58 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
214 schema:familyName Hill
215 schema:givenName C
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601364507.58
217 rdf:type schema:Person
218 sg:person.0660375370.75 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
219 schema:familyName Taylor
220 schema:givenName M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660375370.75
222 rdf:type schema:Person
223 sg:person.0770006625.60 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
224 schema:familyName Jacques
225 schema:givenName N
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770006625.60
227 rdf:type schema:Person
228 sg:pub.10.1038/nature04186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001795574
229 https://doi.org/10.1038/nature04186
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/nm1101-1194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050308225
232 https://doi.org/10.1038/nm1101-1194
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/nm1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020541056
235 https://doi.org/10.1038/nm1200
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/nm988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003700365
238 https://doi.org/10.1038/nm988
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/nrc1946 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018735013
241 https://doi.org/10.1038/nrc1946
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/nrc2442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013847179
244 https://doi.org/10.1038/nrc2442
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/sj.bjc.6604383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035947940
247 https://doi.org/10.1038/sj.bjc.6604383
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/sj.bjc.6605477 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020767820
250 https://doi.org/10.1038/sj.bjc.6605477
251 rdf:type schema:CreativeWork
252 sg:pub.10.1186/1479-5876-5-32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001875982
253 https://doi.org/10.1186/1479-5876-5-32
254 rdf:type schema:CreativeWork
255 https://app.dimensions.ai/details/publication/pub.1075221300 schema:CreativeWork
256 https://doi.org/10.1016/j.ccr.2006.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000989893
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/j.jim.2008.07.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037057792
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1016/s0022-5347(05)68049-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027421869
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1056/nejmoa065044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007947936
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1073/pnas.0507158102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002444282
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1073/pnas.0708148104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000397108
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1073/pnas.0710516105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004176363
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1093/annonc/mdm367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040378769
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1093/emboj/18.14.3964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000096470
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1097/moh.0b013e32832bbcab schema:sameAs https://app.dimensions.ai/details/publication/pub.1010572209
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1101/gad.436307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023814636
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1126/science.1127592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062453796
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1126/science.1150224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044864905
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1158/0008-5472.can-04-1443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014291431
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1158/1078-0432.ccr-08-2363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038609521
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1160/th04-09-0578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063290288
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1200/jco.2005.01.186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204187
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1200/jco.2008.19.5511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017988502
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1593/neo.05592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034339541
295 rdf:type schema:CreativeWork
296 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
297 schema:name Department of Biostatistics, Institut de Cancérologie Gustave Roussy, Villejuif, France
298 Department of Medicine, Institut de Cancérologie Gustave Roussy, Villejuif, France
299 INSERM U 981 ‘Identification of molecular predictors and new targets for cancer treatment’, Institut de Cancérologie Gustave Roussy, University of Paris-Sud, Villejuif, France
300 Translational Research Laboratory, Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France
301 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...